[go: up one dir, main page]

CN117736962A - Fermentation medium and application thereof in preparation of teriparatide - Google Patents

Fermentation medium and application thereof in preparation of teriparatide Download PDF

Info

Publication number
CN117736962A
CN117736962A CN202311681973.1A CN202311681973A CN117736962A CN 117736962 A CN117736962 A CN 117736962A CN 202311681973 A CN202311681973 A CN 202311681973A CN 117736962 A CN117736962 A CN 117736962A
Authority
CN
China
Prior art keywords
fermentation
sulfate
trace element
solvent
pure water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN202311681973.1A
Other languages
Chinese (zh)
Inventor
陈波
孙航
于方
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yifan Pharmaceutical Shanghai Co ltd
Original Assignee
Yifan Pharmaceutical Shanghai Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yifan Pharmaceutical Shanghai Co ltd filed Critical Yifan Pharmaceutical Shanghai Co ltd
Priority to CN202311681973.1A priority Critical patent/CN117736962A/en
Publication of CN117736962A publication Critical patent/CN117736962A/en
Priority to CN202410859533.9A priority patent/CN118703415B/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/38Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/635Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/185Escherichia
    • C12R2001/19Escherichia coli

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention provides a fermentation medium and application thereof in preparation of teriparatide, and belongs to the technical field of biological pharmacy. The fermentation medium comprises the following components: yeast peptone, yeast extract powder, dipotassium phosphate, potassium dihydrogen phosphate, ammonium sulfate, magnesium sulfate heptahydrate, glycerol, microelement solution, defoamer and pure water as solvent. The microelement solution added in the fermentation culture medium is more beneficial to the expression of inclusion bodies by controlling the types and the addition amount of the microelement, and the strategy of starting and adjusting the feeding flow rate at a fixed time point is adopted in the fermentation process, so that the stability of fermentation production is improved.

Description

发酵培养基及其在特立帕肽制备中的应用Fermentation medium and its application in the preparation of teriparatide

技术领域Technical field

本发明属于生物制药技术领域,具体涉及一种发酵培养基及其在特立帕肽制备中的应用。The invention belongs to the technical field of biopharmaceuticals, and specifically relates to a fermentation culture medium and its application in the preparation of teriparatide.

背景技术Background technique

骨质疏松症(Osteoporosis,OP)是一种由多种原因引起的骨丢失和骨质量下降,导致骨脆性增加,直至发生骨折的代谢性骨病。骨质疏松症可分为原发性和继发性型,Ⅰ型原发性骨质疏松症发生于绝经后女性,Ⅱ型原发性骨质疏松症见于老年人。骨质疏松症引起的骨折危险,严重影响患者的心身及生活质量。骨质疏松症往往早期无显著的临床症状,所以被叫为“寂静的杀手”,因此早期预防和治疗具有重要的意义。目前临床上常采用的药物主要有促进骨矿化类、抗骨吸收类和增强骨合成类三大类药物。Osteoporosis (OP) is a metabolic bone disease caused by bone loss and bone quality reduction caused by a variety of reasons, leading to increased bone fragility until fracture occurs. Osteoporosis can be divided into primary and secondary types. Type I primary osteoporosis occurs in postmenopausal women, and type II primary osteoporosis occurs in the elderly. The risk of fractures caused by osteoporosis seriously affects patients' physical and mental health and quality of life. Osteoporosis often has no obvious clinical symptoms in the early stages, so it is called the "silent killer". Therefore, early prevention and treatment are of great significance. Currently, there are three main types of drugs commonly used in clinical practice: those that promote bone mineralization, those that resist bone resorption, and those that enhance bone synthesis.

特立帕肽分子式为C181H291N55O51S2,分子量为4117.72,理论等电点8.29,是甲状旁腺激素(PTH)衍生物,是含有84个氨基酸人内源性甲状旁腺素的N末端区域具有生物活性的1-34氨基酸片段,其免疫学和生物学特性与内源性甲状旁腺素完全相同。The molecular formula of teriparatide is C 181 H 291 N 55 O 51 S 2 , the molecular weight is 4117.72, and the theoretical isoelectric point is 8.29. It is a derivative of parathyroid hormone (PTH) and contains 84 amino acids of human endogenous parathyroid gland. The N-terminal region of parathyroid hormone has a biologically active 1-34 amino acid fragment, and its immunological and biological properties are exactly the same as endogenous parathyroid hormone.

特立帕肽是一种抗骨质疏松症,有助于调节钙代谢,促进骨形成的药物。通过增加成骨细胞活性及数量促新骨形成,提高骨强度,有效降低椎体和非脊柱骨折风险,改善背痛,提高行动能力。该药物促进新骨的生长,而其他骨质疏松症药物通过抑制骨吸收或分解来提高骨密度。Teriparatide is an anti-osteoporosis drug that helps regulate calcium metabolism and promote bone formation. By increasing the activity and number of osteoblasts, it promotes new bone formation, improves bone strength, effectively reduces the risk of vertebral and non-vertebral fractures, improves back pain, and improves mobility. This drug promotes the growth of new bone, whereas other osteoporosis drugs increase bone density by inhibiting bone resorption or breakdown.

特立帕肽(Teriparatide)是第一种获得美国食品及药物管理局FDA批准的骨形成剂类新药,适用于有骨折高发风险的绝经后妇女骨质疏松症的治疗,显著降低绝经后妇女椎骨和非椎骨骨折风险。特立帕肽注射液在2002年11月FDA批准上市,随后在2003年6月EMEA批准上市,2010年7月PMDA批准上市。2011年3月,特立帕肽注射液获批进入我国药物市场,被国家食品药品监督管理局批准在中国用于治疗严重骨质疏松的绝经后女性患者。Teriparatide is the first new bone-forming agent approved by the U.S. Food and Drug Administration. It is suitable for the treatment of osteoporosis in postmenopausal women with a high risk of fractures. It can significantly reduce the number of vertebrae in postmenopausal women. and risk of nonvertebral fractures. Teriparatide injection was approved by the FDA in November 2002, then by the EMEA in June 2003, and by the PMDA in July 2010. In March 2011, teriparatide injection was approved to enter the Chinese drug market and was approved by the State Food and Drug Administration for the treatment of postmenopausal female patients with severe osteoporosis in China.

特立帕肽的制备普遍采用基因工程菌发酵的方法。如何提高特立帕肽发酵产量,从而逐渐成为热点。The preparation of teriparatide generally adopts the fermentation method of genetically engineered bacteria. How to improve the fermentation yield of teriparatide has gradually become a hot topic.

采用大肠杆菌进行特立帕肽重组表达在一些文献和专利中已有报道。比如,授权专利CN110938151B中,冯强等构建pET28a-HSTP/BL21(DE3)工程菌,采用含50μg/ml卡那霉素的TB培养基,在60L发酵体积中培养5小时并用IPTG诱导3小时。三批发酵的平均湿菌种分别为66.7、65.4和66.7g/L,平均包涵体得率分别为11.6、9.3和8.3g/L。Recombinant expression of teriparatide using Escherichia coli has been reported in some literature and patents. For example, in the authorized patent CN110938151B, Feng Qiang et al. constructed pET28a-HSTP/BL21 (DE3) engineering bacteria, using TB medium containing 50 μg/ml kanamycin, cultured in a 60L fermentation volume for 5 hours and induced with IPTG for 3 hours. The average wet bacterial strains of the three batches of fermentation were 66.7, 65.4 and 66.7g/L respectively, and the average inclusion body yields were 11.6, 9.3 and 8.3g/L respectively.

通过增加氧气供应,实现高密度发酵,对于提高重组蛋白产品的表达也已有尝试。中国专利CN111378027B中,文良柱等尝试采用高密发酵的方式进行索马鲁肽前体(与特立帕肽大小相近)的重组表达,该工程菌同样采用BL21(DE3)宿主菌,以包涵体方式表达目的多肽。该研究以葡萄糖10g/L,酵母粉:30g/L,磷酸二氢钾4g/L,磷酸氢二钠4g/L,硫酸铵6g/L,二水氯化钙0.02g/L,七水硫酸镁10g/L作为发酵培养基,以酵母粉:20g/L,葡萄糖:30g/L作为补料培养基;控制温度在34℃、pH6.9左右,溶解氧30%以上,采用IPTG诱导6小时后采用此表达方式,使发酵的湿菌重提高至145g/L。在另一篇中国专利CN 104592381 A中,文良柱等尝试采用高密发酵的方式进行利拉鲁肽(与特立帕肽大小相近)的重组表达,该工程菌同样采用BL21(DE3)宿主菌,以包涵体方式表达目的多肽。该研究以葡萄糖10g/L;酵母粉:30g/L;磷酸氢二钠4g/L;磷酸二氢钾4g/L;硫酸铵6g/L;七水硫酸镁10g/L;二水氯化钙0.02g/L;VB1微量作为发酵培养基,以酵母粉:20g/L,葡萄糖:30g/L作为补料培养基;在补料6h后,控制温度30℃、pH7.0左右、溶氧30%,采用IPTG诱导6小时后采用此表达方式,使发酵的湿菌重提高至178g/L,包涵体湿重为30g/L发酵液。By increasing oxygen supply to achieve high-density fermentation, there have also been attempts to improve the expression of recombinant protein products. In Chinese patent CN111378027B, Wen Liangzhu and others tried to use high-density fermentation to recombinantly express the semaglutide precursor (similar in size to teriparatide). The engineering strain also used the BL21 (DE3) host strain in the form of inclusion bodies. Express the polypeptide of interest. In this study, glucose 10g/L, yeast powder: 30g/L, potassium dihydrogen phosphate 4g/L, disodium hydrogenphosphate 4g/L, ammonium sulfate 6g/L, calcium chloride dihydrate 0.02g/L, sulfuric acid heptahydrate Magnesium 10g/L is used as the fermentation medium, yeast powder: 20g/L, glucose: 30g/L are used as the feed medium; control the temperature at 34°C, pH around 6.9, dissolved oxygen above 30%, and use IPTG for induction for 6 hours This expression method was later used to increase the wet bacterial weight of fermentation to 145g/L. In another Chinese patent CN 104592381 A, Wen Liangzhu and others tried to use high-density fermentation to recombinantly express liraglutide (similar in size to teriparatide). The engineering strain also used the BL21 (DE3) host strain. Express the target polypeptide in the form of inclusion bodies. In this study, glucose 10g/L; yeast powder: 30g/L; disodium hydrogen phosphate 4g/L; potassium dihydrogen phosphate 4g/L; ammonium sulfate 6g/L; magnesium sulfate heptahydrate 10g/L; calcium chloride dihydrate 0.02g/L; VB1 trace as fermentation medium, yeast powder: 20g/L, glucose: 30g/L as feeding medium; after feeding for 6 hours, control the temperature to 30°C, pH around 7.0, and dissolved oxygen to 30 %, using this expression method after IPTG induction for 6 hours, the wet bacterial weight of fermentation was increased to 178g/L, and the wet weight of inclusion bodies was 30g/L fermentation broth.

通过设备改造,用于适应特立帕肽高密发酵的设计也有所报道。比如中国专利CN219174485 U中,邓全宇等通过对搅拌桨的优化提高特立帕肽发酵时的搅拌效果,但是该专利并未公布特立帕肽高密发酵具体工艺及特立帕肽包涵体表达水平。Through equipment modification, designs adapted to high-density fermentation of teriparatide have also been reported. For example, in Chinese patent CN219174485 U, Deng Quanyu and others improved the stirring effect during teriparatide fermentation by optimizing the stirring paddle. However, the patent did not disclose the specific process of high-density fermentation of teriparatide and the expression level of teriparatide inclusion bodies.

但是现有的方法制备的特立帕肽大肠杆菌高密度发酵包涵体产量较低,不能更好地满足需求,因此亟需开发一种能够提高特立帕肽在大肠杆菌高密度发酵中产量的发酵培养基及发酵方法。However, the yield of teriparatide prepared by existing methods in E. coli high-density fermentation inclusion bodies is low and cannot better meet the demand. Therefore, there is an urgent need to develop a method that can increase the yield of teriparatide in E. coli high-density fermentation. Fermentation medium and fermentation method.

发明内容Contents of the invention

基于现有技术中存在的不足,本发明通过对特立帕肽发酵条件的优化,得到一种发酵培养基,该发酵培养基能够提高特立帕肽在大肠杆菌高密度发酵中包涵体产量。Based on the deficiencies in the prior art, the present invention obtains a fermentation medium by optimizing the fermentation conditions of teriparatide, which can increase the production of inclusion bodies of teriparatide in high-density fermentation of E. coli.

本发明所述的发酵培养基可使特立帕肽大肠杆菌高密度发酵的包涵体产量提高到40-45g/L的水平。The fermentation medium of the present invention can increase the inclusion body yield of high-density fermentation of E. coli teriparat to a level of 40-45g/L.

为了实现上述目的,本发明采用如下技术方案实现:In order to achieve the above objects, the present invention adopts the following technical solutions:

一方面,本发明提供了一种发酵培养基,所述的发酵培养基包括如下组分:酵母蛋白胨12-20g/L,酵母浸粉4-10g/L,三水磷酸氢二钾3-5g/L,磷酸二氢钾0.5-2g/L,硫酸铵0.5-3g/L,七水硫酸镁0.5-2g/L,甘油3-10g/L,微量元素溶液1-3ml/L,消泡剂0.1-0.5g/L,溶剂为纯水,用2mol/L氢氧化钠溶液调节pH6.8-7.2;On the one hand, the invention provides a fermentation medium, which includes the following components: yeast peptone 12-20g/L, yeast extract powder 4-10g/L, and dipotassium hydrogen phosphate trihydrate 3-5g. /L, potassium dihydrogen phosphate 0.5-2g/L, ammonium sulfate 0.5-3g/L, magnesium sulfate heptahydrate 0.5-2g/L, glycerin 3-10g/L, trace element solution 1-3ml/L, defoaming agent 0.1-0.5g/L, the solvent is pure water, use 2mol/L sodium hydroxide solution to adjust pH to 6.8-7.2;

所述的微量元素溶液中含有硫酸镍、四氯化钛和亚铬酸亚铁。The trace element solution contains nickel sulfate, titanium tetrachloride and ferrous chromite.

优选地,所述的硫酸镍、四氯化钛和亚铬酸亚铁的浓度分别为1-3g/L、0.5-2g/L和10-20g/L。Preferably, the concentrations of nickel sulfate, titanium tetrachloride and ferrous chromite are 1-3g/L, 0.5-2g/L and 10-20g/L respectively.

再优选地,所述的微量元素溶液还包括如下组分:二水合乙二胺四乙酸二钠、硫酸锰、二水钼酸钠、氯化钴、硫酸锌、硫酸铜和硼酸,溶剂为纯水。Preferably, the trace element solution also includes the following components: disodium ethylenediaminetetraacetate dihydrate, manganese sulfate, sodium molybdate dihydrate, cobalt chloride, zinc sulfate, copper sulfate and boric acid, and the solvent is pure water.

进一步优选地,所述的微量元素溶液还包括如下组分:二水合乙二胺四乙酸二钠20-30g/L,硫酸锰8-10g/L,二水钼酸钠0.5-1.5g/L,氯化钴16-20g/L,硫酸锌6-10g/L,硫酸铜4-6g/L和硼酸2-4g/L,溶剂为纯水。Further preferably, the trace element solution also includes the following components: disodium ethylenediaminetetraacetate dihydrate 20-30g/L, manganese sulfate 8-10g/L, sodium molybdate dihydrate 0.5-1.5g/L , cobalt chloride 16-20g/L, zinc sulfate 6-10g/L, copper sulfate 4-6g/L and boric acid 2-4g/L, the solvent is pure water.

作为一些优选地实施方案,所述的微量元素溶液包括如下组分:二水合乙二胺四乙酸二钠20-30g/L,硫酸锰8-10g/L,亚铬酸亚铁10-20g/L,硫酸镍1-3g/L,氯化钴16-20g/L,四氯化钛0.5-2g/L,硫酸锌6-10g/L,硫酸铜4-6g/L,二水钼酸钠0.5-1.5g/L,硼酸2-4g/L,溶剂为纯水。As some preferred embodiments, the trace element solution includes the following components: disodium ethylenediaminetetraacetate dihydrate 20-30g/L, manganese sulfate 8-10g/L, ferrous chromite 10-20g/L L, nickel sulfate 1-3g/L, cobalt chloride 16-20g/L, titanium tetrachloride 0.5-2g/L, zinc sulfate 6-10g/L, copper sulfate 4-6g/L, sodium molybdate dihydrate 0.5-1.5g/L, boric acid 2-4g/L, solvent is pure water.

优选地,所述的发酵培养基包括如下组分:酵母蛋白胨15-18g/L,酵母浸粉5-8g/L,三水磷酸氢二钾4-5g/L,磷酸二氢钾1-1.5g/L,硫酸铵1-2g/L,七水硫酸镁1-1.5g/L,甘油5-8g/L,微量元素溶液1.5-2.5ml/L,消泡剂0.2-0.4g/L,溶剂为纯水,用2mol/L氢氧化钠溶液调节pH6.8-7.2;Preferably, the fermentation medium includes the following components: yeast peptone 15-18g/L, yeast extract powder 5-8g/L, dipotassium hydrogen phosphate trihydrate 4-5g/L, potassium dihydrogen phosphate 1-1.5 g/L, ammonium sulfate 1-2g/L, magnesium sulfate heptahydrate 1-1.5g/L, glycerin 5-8g/L, trace element solution 1.5-2.5ml/L, defoaming agent 0.2-0.4g/L, The solvent is pure water, and the pH is adjusted to 6.8-7.2 with 2mol/L sodium hydroxide solution;

所述的微量元素溶液包括如下组分:二水合乙二胺四乙酸二钠22-28g/L,硫酸锰9-10g/L,亚铬酸亚铁12-18g/L,硫酸镍1.5-2.5g/L,氯化钴17-19g/L,四氯化钛1-1.5g/L,硫酸锌7-9g/L,硫酸铜4.5-5.5g/L,二水钼酸钠1-1.5g/L,硼酸2.5-3.5g/L,溶剂为纯水。The trace element solution includes the following components: disodium ethylenediaminetetraacetate dihydrate 22-28g/L, manganese sulfate 9-10g/L, ferrous chromite 12-18g/L, nickel sulfate 1.5-2.5 g/L, cobalt chloride 17-19g/L, titanium tetrachloride 1-1.5g/L, zinc sulfate 7-9g/L, copper sulfate 4.5-5.5g/L, sodium molybdate dihydrate 1-1.5g /L, boric acid 2.5-3.5g/L, solvent is pure water.

作为一个优选地实施方案,所述的发酵培养基包括如下组分:酵母蛋白胨20g/L,酵母浸粉10g/L,三水磷酸氢二钾5g/L,磷酸二氢钾2g/L,硫酸铵3g/L,七水硫酸镁2g/L,甘油10g/L,微量元素溶液3ml/L,消泡剂0.5g/L,溶剂为纯水,用2mol/L氢氧化钠溶液调节pH7.2;As a preferred embodiment, the fermentation medium includes the following components: yeast peptone 20g/L, yeast extract powder 10g/L, dipotassium hydrogen phosphate trihydrate 5g/L, potassium dihydrogen phosphate 2g/L, sulfuric acid Ammonium 3g/L, magnesium sulfate heptahydrate 2g/L, glycerin 10g/L, trace element solution 3ml/L, defoaming agent 0.5g/L, solvent is pure water, adjust pH to 7.2 with 2mol/L sodium hydroxide solution ;

所述的微量元素溶液包括如下组分:二水合乙二胺四乙酸二钠30g/L,硫酸锰10g/L,亚铬酸亚铁20g/L,硫酸镍3g/L,氯化钴20g/L,四氯化钛2g/L,硫酸锌10g/L,硫酸铜6g/L,二水钼酸钠1.5g/L,硼酸4g/L,溶剂为纯水。The trace element solution includes the following components: disodium ethylenediaminetetraacetate dihydrate 30g/L, manganese sulfate 10g/L, ferrous chromite 20g/L, nickel sulfate 3g/L, cobalt chloride 20g/L. L, titanium tetrachloride 2g/L, zinc sulfate 10g/L, copper sulfate 6g/L, sodium molybdate dihydrate 1.5g/L, boric acid 4g/L, the solvent is pure water.

作为另一个优选地实施方案,所述的发酵培养基包括如下组分:酵母蛋白胨12g/L,酵母浸粉4g/L,三水磷酸氢二钾3g/L,磷酸二氢钾0.5g/L,硫酸铵0.5g/L,七水硫酸镁0.5g/L,甘油3g/L,微量元素溶液1ml/L,消泡剂0.1g/L,溶剂为纯水,用2mol/L氢氧化钠溶液调节pH6.8;As another preferred embodiment, the fermentation medium includes the following components: yeast peptone 12g/L, yeast extract powder 4g/L, dipotassium hydrogen phosphate trihydrate 3g/L, potassium dihydrogen phosphate 0.5g/L , ammonium sulfate 0.5g/L, magnesium sulfate heptahydrate 0.5g/L, glycerol 3g/L, trace element solution 1ml/L, defoaming agent 0.1g/L, the solvent is pure water, use 2mol/L sodium hydroxide solution Adjust pH6.8;

所述的微量元素溶液包括如下组分:二水合乙二胺四乙酸二钠30g/L,硫酸锰10g/L,亚铬酸亚铁20g/L,硫酸镍3g/L,氯化钴20g/L,四氯化钛2g/L,硫酸锌10g/L,硫酸铜6g/L,二水钼酸钠1.5g/L,硼酸4g/L,溶剂为纯水。The trace element solution includes the following components: disodium ethylenediaminetetraacetate dihydrate 30g/L, manganese sulfate 10g/L, ferrous chromite 20g/L, nickel sulfate 3g/L, cobalt chloride 20g/L. L, titanium tetrachloride 2g/L, zinc sulfate 10g/L, copper sulfate 6g/L, sodium molybdate dihydrate 1.5g/L, boric acid 4g/L, the solvent is pure water.

所述的消泡剂选自有机硅消泡剂、聚合物消泡剂、生物消泡剂(即发酵专用消泡剂)中的一种或几种,优选为生物消泡剂(即发酵专用消泡剂)。The defoaming agent is selected from one or more of silicone defoaming agents, polymer defoaming agents, and biological defoaming agents (i.e., fermentation-specific defoaming agents), and is preferably a biological defoaming agent (i.e., fermentation-specific defoaming agents). defoaming agent).

另一方面,本发明还提供了上述发酵培养基在特立帕肽制备中的应用。On the other hand, the present invention also provides the use of the above fermentation medium in the preparation of teriparatide.

再一方面,本发明还提供了采用上述发酵培养基制备特立帕肽包涵体的方法,包括以下步骤:On the other hand, the present invention also provides a method for preparing teriparatide inclusion bodies using the above-mentioned fermentation medium, including the following steps:

(1)先将除微量元素溶液以外的其他组分配置成培养基A,然后将微量元素溶液经过滤后加入培养基A中,得到发酵培养基;再将种子液接入培养基,进行发酵;(1) First configure other components except the trace element solution into culture medium A, then filter the trace element solution and add it to culture medium A to obtain a fermentation medium; then add the seed liquid to the culture medium for fermentation ;

(2)当发酵液OD600≥60时加入诱导剂并降温,诱导表达5-7小时后发酵结束,得发酵液;首先离心发酵液收集菌体沉淀,菌体沉淀经重悬、破碎、离心后得到包涵体。(2) When the OD600 of the fermentation broth is ≥ 60, add the inducer and cool down. After 5-7 hours of induced expression, the fermentation is completed and the fermentation broth is obtained. First, centrifuge the fermentation broth to collect the bacterial precipitate. The bacterial precipitate is resuspended, broken, and centrifuged. Inclusion bodies were obtained.

作为一些优选地实施方案,步骤(1)所述的过滤为采用0.22微米滤膜过滤。As some preferred embodiments, the filtration described in step (1) is filtration using a 0.22 micron filter membrane.

步骤(1)中所述的种子液的接种量为5-10v/v%,初始培养条件37℃,pH6.7-7.3,溶解氧≥30%。The inoculum amount of the seed liquid described in step (1) is 5-10v/v%, the initial culture conditions are 37°C, pH 6.7-7.3, and dissolved oxygen ≥ 30%.

所述的溶氧量通过搅拌转速和通气量及氧气控制,其中空气和氧气的总通气量为1-1.5vvm。The amount of dissolved oxygen is controlled by the stirring speed, ventilation volume and oxygen, wherein the total ventilation volume of air and oxygen is 1-1.5vvm.

步骤(1)中所述的发酵过程中需流加补料,并随着微生物菌体的密度提高需要逐渐增加补料的流速。During the fermentation process described in step (1), feed needs to be fed, and as the density of the microbial cells increases, the flow rate of the feed needs to be gradually increased.

具体变速补料方案如下:培养1小时后开始补料2.5ml/h·L-1,1.5小时后提高为5ml/h·L-1,之后每隔30分钟提高补料速度5ml/h·L-1,最高到35ml/h·L-1,当OD600≥30时补料速度提高为40ml/h·L-1The specific variable speed feeding plan is as follows: start feeding 2.5ml/h·L -1 after 1 hour of culture, increase to 5ml/h·L -1 after 1.5 hours, and then increase the feeding speed by 5ml/h·L every 30 minutes. -1 , up to 35ml/h·L -1 , when OD600≥30, the feeding speed increases to 40ml/h·L -1 .

其中,所述的补料包括如下组分:酵母蛋白胨180-220g/L,酵母浸粉80-120g/L,甘油350-400g/L,消泡剂1-2g/L,溶剂为纯水;Wherein, the supplement includes the following components: yeast peptone 180-220g/L, yeast extract powder 80-120g/L, glycerol 350-400g/L, defoaming agent 1-2g/L, and the solvent is pure water;

作为一个优选地实施方案,所述的补料包括如下组分:酵母蛋白胨220g/L,酵母浸粉120g/L,甘油400g/L,消泡剂2g/L,溶剂为纯水。As a preferred embodiment, the feed includes the following components: yeast peptone 220g/L, yeast extract powder 120g/L, glycerol 400g/L, defoaming agent 2g/L, and the solvent is pure water.

所述的消泡剂为生物消泡剂。The defoaming agent is a biological defoaming agent.

步骤(2)中所述的诱导剂为IPTG,所述的诱导剂的加入量为0.1-0.5mmol/L;所述的降温温度为30℃。The inducer described in step (2) is IPTG, the addition amount of the inducer is 0.1-0.5 mmol/L; the cooling temperature is 30°C.

步骤(3)中所述的重悬操作为:向菌体沉淀中加入破菌缓冲液后重悬,得重悬液;所述的菌体沉淀与破菌缓冲液的质量体积比为1kg:5-20L。The resuspension operation described in step (3) is: add sterilization buffer to the bacterial sediment and resuspend to obtain a resuspension; the mass-to-volume ratio of the bacterial sediment to the sterile buffer is 1kg: 5-20L.

所述的破菌缓冲液包括如下组分:三羟甲基氨基甲烷4-8g/L,二水合乙二胺四乙酸二钠0.2-0.5g/L,溶剂为纯水。The bacteriolysis buffer includes the following components: trishydroxymethylaminomethane 4-8g/L, disodium ethylenediaminetetraacetate dihydrate 0.2-0.5g/L, and the solvent is pure water.

作为一个优选地实施方案,所述的破菌缓冲液包括如下组分:三羟甲基氨基甲烷8g/L,二水合乙二胺四乙酸二钠0.5g/L,溶剂为纯水。As a preferred embodiment, the bacteriolysis buffer includes the following components: 8 g/L trishydroxymethylaminomethane, 0.5 g/L disodium ethylenediaminetetraacetate dihydrate, and the solvent is pure water.

作为另一个优选地实施方案,所述的破菌缓冲液包括如下组分:三羟甲基氨基甲烷4g/L,二水合乙二胺四乙酸二钠0.2g/L,溶剂为纯水。As another preferred embodiment, the bacteriolysis buffer includes the following components: 4 g/L trishydroxymethylaminomethane, 0.2 g/L disodium ethylenediaminetetraacetate dihydrate, and the solvent is pure water.

与现有技术相比,本申请的有益效果在于:Compared with the existing technology, the beneficial effects of this application are:

1、本发明所述特立帕肽高密度发酵培养基组成成分明确,来源稳定,在生物药的生产中更有利于产品质量的保证;1. The teriparatide high-density fermentation medium of the present invention has clear composition and stable source, which is more conducive to ensuring product quality in the production of biological drugs;

2、本发明所述特立帕肽高密度发酵培养基中添加的微量元素溶液,其组成更有利于包涵体的表达;2. The composition of the trace element solution added to the teriparatide high-density fermentation medium of the present invention is more conducive to the expression of inclusion bodies;

3、本发明所述特立帕肽高密度发酵方法,采用固定时间点开始和调整补料流量的策略,更利于发酵生产的稳定性。3. The teriparatide high-density fermentation method of the present invention adopts a strategy of starting at a fixed time point and adjusting the feeding flow rate, which is more conducive to the stability of fermentation production.

4、本发明所述特立帕肽高密度发酵方法,采用低温诱导的方法,更有利于在发酵环境中降低诱导剂对菌体生长的副作用,提高表达率。4. The high-density fermentation method of teriparatide of the present invention adopts a low-temperature induction method, which is more conducive to reducing the side effects of the inducer on bacterial growth in the fermentation environment and increasing the expression rate.

具体实施方式Detailed ways

以下结合实施例对本发明的原理和特征进行描述,所举实例只用于解释本发明,并非用于限定本发明的范围。实施例中未注明具体条件者,按照常规条件或制造商建议的条件进行。所用试剂未注明生产厂商者,均为可以通过市售购买获得的常规产品,以下实施例中所使用的消泡剂购自烟台恒鑫化工科技有限公司,型号为THIX-298高效发酵专用消泡剂。The principles and features of the present invention are described below with reference to examples. The examples are only used to explain the present invention and are not intended to limit the scope of the present invention. If the specific conditions are not specified in the examples, the conditions should be carried out according to the conventional conditions or the conditions recommended by the manufacturer. If the manufacturer of the reagents used is not indicated, they are all conventional products that can be purchased on the market. The defoaming agent used in the following examples was purchased from Yantai Hengxin Chemical Technology Co., Ltd., and the model is THIX-298 high-efficiency fermentation special disinfectant. Foaming agent.

实施例1一种发酵培养基及其在特立帕肽制备中的应用Example 1 A fermentation medium and its application in the preparation of teriparatide

所述的发酵培养基包括如下组分:酵母蛋白胨12g/L,酵母浸粉4g/L,三水磷酸氢二钾3g/L,磷酸二氢钾0.5g/L,硫酸铵0.5g/L,七水硫酸镁0.5g/L,甘油3g/L,微量元素溶液1ml/L,消泡剂0.1g/L,溶剂为纯水,用2mol/L氢氧化钠溶液调节pH6.95;The fermentation medium includes the following components: yeast peptone 12g/L, yeast extract powder 4g/L, dipotassium hydrogen phosphate trihydrate 3g/L, potassium dihydrogen phosphate 0.5g/L, ammonium sulfate 0.5g/L, Magnesium sulfate heptahydrate 0.5g/L, glycerol 3g/L, trace element solution 1ml/L, defoaming agent 0.1g/L, the solvent is pure water, and 2mol/L sodium hydroxide solution is used to adjust pH to 6.95;

所述的微量元素溶液包括如下组分:二水合乙二胺四乙酸二钠20g/L,硫酸锰8g/L,亚铬酸亚铁10g/L,硫酸镍1g/L,氯化钴16g/L,四氯化钛0.5g/L,硫酸锌6g/L,硫酸铜4g/L,二水钼酸钠0.5g/L,硼酸2g/L,溶剂为纯水。The trace element solution includes the following components: disodium ethylenediaminetetraacetate dihydrate 20g/L, manganese sulfate 8g/L, ferrous chromite 10g/L, nickel sulfate 1g/L, cobalt chloride 16g/L. L, titanium tetrachloride 0.5g/L, zinc sulfate 6g/L, copper sulfate 4g/L, sodium molybdate dihydrate 0.5g/L, boric acid 2g/L, the solvent is pure water.

制备特立帕肽包涵体的方法,包括以下步骤:The method for preparing teriparatide inclusion bodies includes the following steps:

(1)先将除微量元素溶液以外的其他组分配置成培养基A,将微量元素溶液经0.22微米滤膜过滤后加入培养基A中,得发酵培养基,然后将种子液(OD6004.5)接入培养基中进行发酵,接种量5v/v%,初始培养条件37℃,pH7.0,通过搅拌转速和通气量及氧气控制溶解氧≥30%,其中空气和氧气的总通气量1vvm;(1) First configure other components except the trace element solution into culture medium A. Filter the trace element solution through a 0.22 micron filter membrane and add it to culture medium A to obtain the fermentation culture medium. Then add the seed liquid (OD 600 4.5 ) is inserted into the culture medium for fermentation, the inoculum volume is 5v/v%, the initial culture conditions are 37°C, pH 7.0, and the dissolved oxygen is controlled to ≥ 30% through stirring speed, ventilation and oxygen, and the total ventilation of air and oxygen is 1vvm ;

所述的发酵过程中需要变速补料,具体为:培养1小时后开始补料2.5ml/h·L-1,1.5小时后提高为5ml/h·L-1,之后每隔30分钟提高补料速度5ml/h·L-1,最高到35ml/h·L-1,当OD600≥30时补料速度提高为40ml/h·L-1The fermentation process requires variable speed feeding, specifically: starting to feed 2.5ml/h·L -1 after 1 hour of cultivation, increasing to 5ml/h·L -1 after 1.5 hours, and then increasing the feed every 30 minutes. The feeding speed is 5ml/h·L -1 , up to 35ml/h·L -1 . When OD 600 ≥ 30, the feeding speed is increased to 40ml/h·L -1 ;

(2)当发酵液OD600≥60时加入诱导剂IPTG,加量为0.1mmol/L,将发酵控制温度降低到30℃,诱导表达5小时后发酵结束,得发酵液;离心发酵液收集菌体沉淀,菌体经破菌缓冲液重悬(1kg菌体加入10L破菌缓冲液)得重悬液,重悬液经高压均质机破碎后再次离心,收集离心沉淀即为包涵体。(2) When the OD 600 of the fermentation broth is ≥60, add the inducer IPTG at an amount of 0.1 mmol/L. Reduce the fermentation control temperature to 30°C. After inducing expression for 5 hours, the fermentation is completed to obtain the fermentation broth; centrifuge the fermentation broth to collect the bacteria. The cells are precipitated, and the cells are resuspended in sterilization buffer (1kg of cells is added to 10L of sterilization buffer) to obtain a resuspension. The resuspension is broken by a high-pressure homogenizer and centrifuged again. The centrifugal precipitate is collected as inclusion bodies.

步骤(1)中所述的补料包括如下组分:酵母蛋白胨180g/L,酵母浸粉80g/L,甘油350g/L,消泡剂1g/L,溶剂为纯水。The feed material described in step (1) includes the following components: yeast peptone 180g/L, yeast extract powder 80g/L, glycerol 350g/L, defoaming agent 1g/L, and the solvent is pure water.

步骤(2)中所述的破菌缓冲液包括如下组分:三羟甲基氨基甲烷4g/L,二水合乙二胺四乙酸二钠0.2g/L,溶剂为纯水。The bacteriolysis buffer described in step (2) includes the following components: trishydroxymethylaminomethane 4g/L, disodium ethylenediaminetetraacetate dihydrate 0.2g/L, and the solvent is pure water.

称重计算得包涵体产量为0.243g/g菌体,40.1g/L发酵液The inclusion body yield calculated by weighing was 0.243g/g of bacterial cells and 40.1g/L of fermentation broth .

实施例2一种发酵培养基及其在特立帕肽制备中的应用Example 2 A fermentation medium and its application in the preparation of teriparatide

所述的发酵培养基包括如下组分:酵母蛋白胨20g/L,酵母浸粉10g/L,三水磷酸氢二钾5g/L,磷酸二氢钾2g/L,硫酸铵3g/L,七水硫酸镁2g/L,甘油10g/L,微量元素溶液3ml/L,消泡剂0.5g/L,溶剂为纯水,用2mol/L氢氧化钠溶液调节pH7.1;The fermentation medium includes the following components: yeast peptone 20g/L, yeast extract powder 10g/L, dipotassium hydrogen phosphate trihydrate 5g/L, potassium dihydrogen phosphate 2g/L, ammonium sulfate 3g/L, heptahydrate Magnesium sulfate 2g/L, glycerol 10g/L, trace element solution 3ml/L, defoaming agent 0.5g/L, solvent is pure water, adjust pH to 7.1 with 2mol/L sodium hydroxide solution;

所述的微量元素溶液包括如下组分:二水合乙二胺四乙酸二钠20g/L,硫酸锰8g/L,亚铬酸亚铁10g/L,硫酸镍1g/L,氯化钴16g/L,四氯化钛0.5g/L,硫酸锌6g/L,硫酸铜4g/L,二水钼酸钠0.5g/L,硼酸2g/L,溶剂为纯水。The trace element solution includes the following components: disodium ethylenediaminetetraacetate dihydrate 20g/L, manganese sulfate 8g/L, ferrous chromite 10g/L, nickel sulfate 1g/L, cobalt chloride 16g/L. L, titanium tetrachloride 0.5g/L, zinc sulfate 6g/L, copper sulfate 4g/L, sodium molybdate dihydrate 0.5g/L, boric acid 2g/L, the solvent is pure water.

制备特立帕肽包涵体的方法,包括以下步骤:The method for preparing teriparatide inclusion bodies includes the following steps:

(1)先将除微量元素溶液以外的其他组分配置成培养基A,将微量元素溶液经0.22微米滤膜过滤后加入培养基A中,得发酵培养基,然后将种子液(OD6004.5)接入培养基中进行发酵,接种量6v/v%,初始培养条件37℃,pH7.0,通过搅拌转速和通气量及氧气控制溶解氧≥30%,其中空气和氧气的总通气量1vvm;(1) First configure other components except the trace element solution into culture medium A. Filter the trace element solution through a 0.22 micron filter membrane and add it to culture medium A to obtain the fermentation culture medium. Then add the seed liquid (OD 600 4.5 ) is inserted into the culture medium for fermentation, the inoculum volume is 6v/v%, the initial culture conditions are 37°C, pH 7.0, and the dissolved oxygen is controlled to ≥ 30% through stirring speed, ventilation and oxygen, and the total ventilation of air and oxygen is 1vvm ;

所述的发酵过程中需要变速补料,具体为:培养1小时后开始补料2.5ml/h·L-1,1.5小时后提高为5ml/h·L-1,之后每隔30分钟提高补料速度5ml/h·L-1,最高到35ml/h·L-1,当OD600≥30时补料速度提高为40ml/h·L-1The fermentation process requires variable speed feeding, specifically: starting to feed 2.5ml/h·L -1 after 1 hour of cultivation, increasing to 5ml/h·L -1 after 1.5 hours, and then increasing the feed every 30 minutes. The feeding speed is 5ml/h·L -1 , up to 35ml/h·L -1 . When OD 600 ≥ 30, the feeding speed is increased to 40ml/h·L -1 ;

(2)当发酵液OD600≥60时加入诱导剂IPTG,加量为0.2mmol/L,将发酵控制温度降低到30℃,诱导表达5小时后发酵结束,得发酵液;离心发酵液收集菌体沉淀,菌体经破菌缓冲液重悬(1kg菌体加入10L破菌缓冲液)得重悬液,重悬液经高压均质机破碎后再次离心,收集离心沉淀即为包涵体。(2) When the OD 600 of the fermentation broth is ≥60, add the inducer IPTG at an amount of 0.2 mmol/L. Reduce the fermentation control temperature to 30°C. After inducing expression for 5 hours, the fermentation is completed to obtain the fermentation broth; centrifuge the fermentation broth to collect the bacteria. The cells are precipitated, and the cells are resuspended in sterilization buffer (1kg of cells is added to 10L of sterilization buffer) to obtain a resuspension. The resuspension is broken by a high-pressure homogenizer and centrifuged again. The centrifugal precipitate is collected as inclusion bodies.

步骤(1)中所述的补料包括如下组分:酵母蛋白胨180g/L,酵母浸粉80g/L,甘油350g/L,消泡剂1g/L,溶剂为纯水。The feed material described in step (1) includes the following components: yeast peptone 180g/L, yeast extract powder 80g/L, glycerol 350g/L, defoaming agent 1g/L, and the solvent is pure water.

步骤(2)中所述的破菌缓冲液包括如下组分:三羟甲基氨基甲烷4g/L,二水合乙二胺四乙酸二钠0.2g/L,溶剂为纯水。The bacteriolysis buffer described in step (2) includes the following components: trishydroxymethylaminomethane 4g/L, disodium ethylenediaminetetraacetate dihydrate 0.2g/L, and the solvent is pure water.

称重计算得包涵体产量为0.241g/g菌体,40.5g/L发酵液The inclusion body yield calculated by weighing was 0.241g/g of bacterial cells and 40.5g/L of fermentation broth .

实施例3一种发酵培养基及其在特立帕肽制备中的应用Embodiment 3 A fermentation medium and its application in the preparation of teriparatide

所述的发酵培养基包括如下组分:酵母蛋白胨12g/L,酵母浸粉4g/L,三水磷酸氢二钾3g/L,磷酸二氢钾0.5g/L,硫酸铵0.5g/L,七水硫酸镁0.5g/L,甘油3g/L,微量元素溶液1ml/L,消泡剂0.1g/L,溶剂为纯水,用2mol/L氢氧化钠溶液调节pH6.8;The fermentation medium includes the following components: yeast peptone 12g/L, yeast extract powder 4g/L, dipotassium hydrogen phosphate trihydrate 3g/L, potassium dihydrogen phosphate 0.5g/L, ammonium sulfate 0.5g/L, Magnesium sulfate heptahydrate 0.5g/L, glycerol 3g/L, trace element solution 1ml/L, defoaming agent 0.1g/L, the solvent is pure water, and 2mol/L sodium hydroxide solution is used to adjust pH to 6.8;

所述的微量元素溶液包括如下组分:二水合乙二胺四乙酸二钠30g/L,硫酸锰10g/L,亚铬酸亚铁20g/L,硫酸镍3g/L,氯化钴20g/L,四氯化钛2g/L,硫酸锌10g/L,硫酸铜6g/L,二水钼酸钠1.5g/L,硼酸4g/L,溶剂为纯水。The trace element solution includes the following components: disodium ethylenediaminetetraacetate dihydrate 30g/L, manganese sulfate 10g/L, ferrous chromite 20g/L, nickel sulfate 3g/L, cobalt chloride 20g/L. L, titanium tetrachloride 2g/L, zinc sulfate 10g/L, copper sulfate 6g/L, sodium molybdate dihydrate 1.5g/L, boric acid 4g/L, the solvent is pure water.

制备特立帕肽包涵体的方法,包括以下步骤:The method for preparing teriparatide inclusion bodies includes the following steps:

(1)先将除微量元素溶液以外的其他组分配置成培养基A,将微量元素溶液经0.22微米滤膜过滤后加入培养基A中,得发酵培养基,然后将种子液(OD6004.5)接入培养基中进行发酵,接种量7v/v%,初始培养条件37℃,pH7.0,通过搅拌转速和通气量及氧气控制溶解氧≥30%,其中空气和氧气的总通气量1vvm;(1) First configure other components except the trace element solution into culture medium A. Filter the trace element solution through a 0.22 micron filter membrane and add it to culture medium A to obtain the fermentation culture medium. Then add the seed liquid (OD 600 4.5 ) is inserted into the culture medium for fermentation, the inoculum volume is 7v/v%, the initial culture conditions are 37°C, pH 7.0, and the dissolved oxygen is controlled to ≥ 30% through stirring speed, ventilation and oxygen, and the total ventilation of air and oxygen is 1vvm ;

所述的发酵过程中需要变速补料,具体为:培养1小时后开始补料2.5ml/h·L-1,1.5小时后提高为5ml/h·L-1,之后每隔30分钟提高补料速度5ml/h·L-1,最高到35ml/h·L-1,当OD600≥30时补料速度提高为40ml/h·L-1The fermentation process requires variable speed feeding, specifically: starting to feed 2.5ml/h·L -1 after 1 hour of cultivation, increasing to 5ml/h·L -1 after 1.5 hours, and then increasing the feed every 30 minutes. The feeding speed is 5ml/h·L -1 , up to 35ml/h·L -1 . When OD 600 ≥ 30, the feeding speed is increased to 40ml/h·L -1 ;

(2)当发酵液OD600≥60时加入诱导剂IPTG,加量为0.2mmol/L,将发酵控制温度降低到30℃,诱导表达5小时后发酵结束,得发酵液;离心发酵液收集菌体沉淀,菌体经破菌缓冲液重悬(1kg菌体加入10L破菌缓冲液)得重悬液,重悬液经高压均质机破碎后再次离心,收集离心沉淀即为包涵体。(2) When the OD 600 of the fermentation broth is ≥60, add the inducer IPTG at an amount of 0.2 mmol/L. Reduce the fermentation control temperature to 30°C. After inducing expression for 5 hours, the fermentation is completed to obtain the fermentation broth; centrifuge the fermentation broth to collect the bacteria. The cells are precipitated, and the cells are resuspended in sterilization buffer (1kg of cells is added to 10L of sterilization buffer) to obtain a resuspension. The resuspension is broken by a high-pressure homogenizer and centrifuged again. The centrifugal precipitate is collected as inclusion bodies.

步骤(1)中所述的补料包括如下组分:酵母蛋白胨220g/L,酵母浸粉120g/L,甘油400g/L,消泡剂2g/L,溶剂为纯水。The feed material described in step (1) includes the following components: yeast peptone 220g/L, yeast extract powder 120g/L, glycerin 400g/L, defoaming agent 2g/L, and the solvent is pure water.

步骤(2)中所述的破菌缓冲液包括如下组分:三羟甲基氨基甲烷4g/L,二水合乙二胺四乙酸二钠0.2g/L,溶剂为纯水。The bacteriolysis buffer described in step (2) includes the following components: trishydroxymethylaminomethane 4g/L, disodium ethylenediaminetetraacetate dihydrate 0.2g/L, and the solvent is pure water.

称重计算得包涵体产量为0.259g/g菌体,43.6g/L发酵液The inclusion body yield calculated by weighing was 0.259g/g of bacterial cells and 43.6g/L of fermentation broth .

实施例4一种发酵培养基及其在特立帕肽制备中的应用Embodiment 4 A fermentation medium and its application in the preparation of teriparatide

所述的发酵培养基包括如下组分:酵母蛋白胨20g/L,酵母浸粉10g/L,三水磷酸氢二钾5g/L,磷酸二氢钾2g/L,硫酸铵3g/L,七水硫酸镁2g/L,甘油10g/L,微量元素溶液3ml/L,消泡剂0.5g/L,溶剂为纯水,用2mol/L氢氧化钠溶液调节pH7.2;The fermentation medium comprises the following components: 20 g/L yeast peptone, 10 g/L yeast extract powder, 5 g/L potassium dihydrogen phosphate trihydrate, 2 g/L potassium dihydrogen phosphate, 3 g/L ammonium sulfate, 2 g/L magnesium sulfate heptahydrate, 10 g/L glycerol, 3 ml/L trace element solution, 0.5 g/L defoamer, the solvent is pure water, and the pH is adjusted to 7.2 with 2 mol/L sodium hydroxide solution;

所述的微量元素溶液包括如下组分:二水合乙二胺四乙酸二钠30g/L,硫酸锰10g/L,亚铬酸亚铁20g/L,硫酸镍3g/L,氯化钴20g/L,四氯化钛2g/L,硫酸锌10g/L,硫酸铜6g/L,二水钼酸钠1.5g/L,硼酸4g/L,溶剂为纯水。The trace element solution includes the following components: disodium ethylenediaminetetraacetate dihydrate 30g/L, manganese sulfate 10g/L, ferrous chromite 20g/L, nickel sulfate 3g/L, cobalt chloride 20g/L. L, titanium tetrachloride 2g/L, zinc sulfate 10g/L, copper sulfate 6g/L, sodium molybdate dihydrate 1.5g/L, boric acid 4g/L, the solvent is pure water.

制备特立帕肽包涵体的方法,包括以下步骤:The method for preparing teriparatide inclusion bodies includes the following steps:

(1)先将除微量元素溶液以外的其他组分配置成培养基A,将微量元素溶液经0.22微米滤膜过滤后加入培养基A中,得发酵培养基,然后将种子液(OD6004.5)接入培养基中进行发酵,接种量6v/v%,初始培养条件37℃,pH7.0,通过搅拌转速和通气量及氧气控制溶解氧≥30%,其中空气和氧气的总通气量1.2vvm;(1) First configure other components except the trace element solution into culture medium A. Filter the trace element solution through a 0.22 micron filter membrane and add it to culture medium A to obtain the fermentation culture medium. Then add the seed liquid (OD 600 4.5 ) is inserted into the culture medium for fermentation, the inoculum volume is 6v/v%, the initial culture conditions are 37°C, pH 7.0, and the dissolved oxygen is controlled to ≥ 30% through the stirring speed, ventilation volume and oxygen, of which the total ventilation volume of air and oxygen is 1.2 vvm;

所述的发酵过程中需要变速补料,具体为:培养1小时后开始补料2.5ml/h·L-1,1.5小时后提高为5ml/h·L-1,之后每隔30分钟提高补料速度5ml/h·L-1,最高到35ml/h·L-1,当OD600≥30时补料速度提高为40ml/h·L-1The fermentation process requires variable speed feeding, specifically: starting to feed 2.5ml/h·L -1 after 1 hour of cultivation, increasing to 5ml/h·L -1 after 1.5 hours, and then increasing the feed every 30 minutes. The feeding speed is 5ml/h·L -1 , up to 35ml/h·L -1 . When OD 600 ≥ 30, the feeding speed is increased to 40ml/h·L -1 ;

(2)当发酵液OD600≥60时加入诱导剂IPTG,加量为0.3mmol/L,将发酵控制温度降低到30℃,诱导表达5小时后发酵结束,得发酵液;离心发酵液收集菌体沉淀,菌体经破菌缓冲液重悬(1kg菌体加入5L破菌缓冲液)得重悬液,重悬液经高压均质机破碎后再次离心,收集离心沉淀即为包涵体。(2) When the OD 600 of the fermentation broth is ≥60, add the inducer IPTG at an amount of 0.3 mmol/L. Reduce the fermentation control temperature to 30°C. After inducing expression for 5 hours, the fermentation is completed to obtain the fermentation broth; centrifuge the fermentation broth to collect the bacteria. The cells are precipitated, and the cells are resuspended in sterilization buffer (1kg of cells is added to 5L of sterilization buffer) to obtain a resuspension. The resuspension is broken by a high-pressure homogenizer and centrifuged again. The centrifugal precipitate is collected as inclusion bodies.

步骤(1)中所述的补料包括如下组分:酵母蛋白胨220g/L,酵母浸粉120g/L,甘油400g/L,消泡剂2g/L,溶剂为纯水。The feed material described in step (1) includes the following components: yeast peptone 220g/L, yeast extract powder 120g/L, glycerin 400g/L, defoaming agent 2g/L, and the solvent is pure water.

步骤(2)中所述的破菌缓冲液包括如下组分:三羟甲基氨基甲烷8g/L,二水合乙二胺四乙酸二钠0.5g/L,溶剂为纯水。The bacteriolysis buffer described in step (2) includes the following components: trishydroxymethylaminomethane 8g/L, disodium ethylenediaminetetraacetate dihydrate 0.5g/L, and the solvent is pure water.

称重计算得包涵体产量为0.279g/g菌体,44.1g/L发酵液The inclusion body yield calculated by weighing was 0.279g/g of bacterial cells and 44.1g/L of fermentation broth .

实施例5一种发酵培养基及其在特立帕肽制备中的应用Example 5 A fermentation medium and its application in the preparation of teriparatide

所述的发酵培养基包括如下组分:酵母蛋白胨12g/L,酵母浸粉4g/L,三水磷酸氢二钾3g/L,磷酸二氢钾0.5g/L,硫酸铵0.5g/L,七水硫酸镁0.5g/L,甘油3g/L,微量元素溶液1ml/L,消泡剂0.1g/L,溶剂为纯水,用2mol/L氢氧化钠溶液调节pH6.8;The fermentation medium includes the following components: yeast peptone 12g/L, yeast extract powder 4g/L, dipotassium hydrogen phosphate trihydrate 3g/L, potassium dihydrogen phosphate 0.5g/L, ammonium sulfate 0.5g/L, Magnesium sulfate heptahydrate 0.5g/L, glycerol 3g/L, trace element solution 1ml/L, defoaming agent 0.1g/L, the solvent is pure water, and 2mol/L sodium hydroxide solution is used to adjust pH to 6.8;

所述的微量元素溶液包括如下组分:二水合乙二胺四乙酸二钠20g/L,硫酸锰8g/L,亚铬酸亚铁10g/L,硫酸镍1g/L,氯化钴16g/L,四氯化钛0.5g/L,硫酸锌6g/L,硫酸铜4g/L,二水钼酸钠0.5g/L,硼酸2g/L,溶剂为纯水。The trace element solution includes the following components: disodium ethylenediaminetetraacetate dihydrate 20g/L, manganese sulfate 8g/L, ferrous chromite 10g/L, nickel sulfate 1g/L, cobalt chloride 16g/L. L, titanium tetrachloride 0.5g/L, zinc sulfate 6g/L, copper sulfate 4g/L, sodium molybdate dihydrate 0.5g/L, boric acid 2g/L, the solvent is pure water.

制备特立帕肽包涵体的方法,包括以下步骤:The method for preparing teriparatide inclusion bodies includes the following steps:

(1)先将除微量元素溶液以外的其他组分配置成培养基A,将微量元素溶液经0.22微米滤膜过滤后加入培养基A中,得发酵培养基,然后将种子液(OD6004.5)接入培养基中进行发酵,接种量8v/v%,初始培养条件37℃,pH7.0,通过搅拌转速和通气量及氧气控制溶解氧≥30%,其中空气和氧气的总通气量1.5vvm;(1) First configure other components except the trace element solution into culture medium A. Filter the trace element solution through a 0.22 micron filter membrane and add it to culture medium A to obtain the fermentation culture medium. Then add the seed liquid (OD 600 4.5 ) is inserted into the culture medium for fermentation, the inoculum volume is 8v/v%, the initial culture conditions are 37°C, pH 7.0, and the dissolved oxygen is controlled to ≥ 30% through the stirring speed, ventilation volume and oxygen, of which the total ventilation volume of air and oxygen is 1.5 vvm;

所述的发酵过程中需要变速补料,具体为:培养1小时后开始补料2.5ml/h·L-1,1.5小时后提高为5ml/h·L-1,之后每隔30分钟提高补料速度5ml/h·L-1,最高到35ml/h·L-1,当OD600≥30时补料速度提高为40ml/h·L-1The fermentation process requires variable speed feeding, specifically: starting to feed 2.5ml/h·L -1 after 1 hour of cultivation, increasing to 5ml/h·L -1 after 1.5 hours, and then increasing the feed every 30 minutes. The feeding speed is 5ml/h·L -1 , up to 35ml/h·L -1 . When OD 600 ≥ 30, the feeding speed is increased to 40ml/h·L -1 ;

(2)当发酵液OD600≥60时加入诱导剂IPTG,加量为0.4mmol/L,将发酵控制温度降低到30℃,诱导表达5小时后发酵结束,得发酵液;离心发酵液收集菌体沉淀,菌体经破菌缓冲液重悬(1kg菌体加入20L破菌缓冲液)得重悬液,重悬液经高压均质机破碎后再次离心,收集离心沉淀即为包涵体。(2) When the OD 600 of the fermentation broth is ≥60, add the inducer IPTG at an amount of 0.4 mmol/L. Reduce the fermentation control temperature to 30°C. After inducing expression for 5 hours, the fermentation is completed to obtain the fermentation broth; centrifuge the fermentation broth to collect the bacteria. The cells are precipitated, and the cells are resuspended in sterilization buffer (20L of sterilization buffer is added to 1kg of cells) to obtain a resuspension. The resuspension is broken by a high-pressure homogenizer and centrifuged again. The centrifugal precipitate is collected as inclusion bodies.

步骤(1)中所述的补料包括如下组分:酵母蛋白胨220g/L,酵母浸粉120g/L,甘油400g/L,消泡剂2g/L,溶剂为纯水。The feed material described in step (1) includes the following components: yeast peptone 220g/L, yeast extract powder 120g/L, glycerin 400g/L, defoaming agent 2g/L, and the solvent is pure water.

步骤(2)中所述的破菌缓冲液包括如下组分:三羟甲基氨基甲烷8g/L,二水合乙二胺四乙酸二钠0.5g/L,溶剂为纯水。The bacteriolysis buffer described in step (2) includes the following components: trishydroxymethylaminomethane 8g/L, disodium ethylenediaminetetraacetate dihydrate 0.5g/L, and the solvent is pure water.

称重计算得包涵体产量为0.252g/g菌体,42.9g/L发酵液The inclusion body yield calculated by weighing was 0.252g/g of bacterial cells and 42.9g/L of fermentation broth .

实施例6一种发酵培养基及其在特立帕肽制备中的应用Example 6 A fermentation medium and its application in the preparation of teriparatide

所述的发酵培养基包括如下组分:酵母蛋白胨20g/L,酵母浸粉10g/L,三水磷酸氢二钾5g/L,磷酸二氢钾2g/L,硫酸铵3g/L,七水硫酸镁2g/L,甘油10g/L,微量元素溶液3ml/L,消泡剂0.5g/L,溶剂为纯水,用2mol/L氢氧化钠溶液调节pH7.2;The fermentation medium includes the following components: yeast peptone 20g/L, yeast extract powder 10g/L, dipotassium hydrogen phosphate trihydrate 5g/L, potassium dihydrogen phosphate 2g/L, ammonium sulfate 3g/L, heptahydrate Magnesium sulfate 2g/L, glycerol 10g/L, trace element solution 3ml/L, defoaming agent 0.5g/L, solvent is pure water, adjust pH to 7.2 with 2mol/L sodium hydroxide solution;

所述的微量元素溶液包括如下组分:二水合乙二胺四乙酸二钠30g/L,硫酸锰10g/L,亚铬酸亚铁20g/L,硫酸镍3g/L,氯化钴20g/L,四氯化钛2g/L,硫酸锌10g/L,硫酸铜6g/L,二水钼酸钠1.5g/L,硼酸4g/L,溶剂为纯水。The trace element solution includes the following components: disodium ethylenediaminetetraacetate dihydrate 30g/L, manganese sulfate 10g/L, ferrous chromite 20g/L, nickel sulfate 3g/L, cobalt chloride 20g/L. L, titanium tetrachloride 2g/L, zinc sulfate 10g/L, copper sulfate 6g/L, sodium molybdate dihydrate 1.5g/L, boric acid 4g/L, the solvent is pure water.

制备特立帕肽包涵体的方法,包括以下步骤:The method for preparing teriparatide inclusion bodies includes the following steps:

(1)先将除微量元素溶液以外的其他组分配置成培养基A,将微量元素溶液经0.22微米滤膜过滤后加入培养基A中,得发酵培养基,然后将种子液(OD6004.5)接入培养基中进行发酵,接种量5v/v%,初始培养条件37℃,pH7.0,通过搅拌转速和通气量及氧气控制溶解氧≥30%,其中空气和氧气的总通气量1vvm;(1) First configure other components except the trace element solution into culture medium A. Filter the trace element solution through a 0.22 micron filter membrane and add it to culture medium A to obtain the fermentation culture medium. Then add the seed liquid (OD 600 4.5 ) is inserted into the culture medium for fermentation, the inoculum volume is 5v/v%, the initial culture conditions are 37°C, pH 7.0, and the dissolved oxygen is controlled to ≥ 30% through stirring speed, ventilation and oxygen, and the total ventilation of air and oxygen is 1vvm ;

所述的发酵过程中需要变速补料,具体为:培养1小时后开始补料2.5ml/h·L-1,1.5小时后提高为5ml/h·L-1,之后每隔30分钟提高补料速度5ml/h·L-1,最高到35ml/h·L-1,当OD600≥30时补料速度提高为40ml/h·L-1The fermentation process requires variable speed feeding, specifically: starting to feed 2.5ml/h·L -1 after 1 hour of cultivation, increasing to 5ml/h·L -1 after 1.5 hours, and then increasing the feed every 30 minutes. The feeding speed is 5ml/h·L -1 , up to 35ml/h·L -1 . When OD 600 ≥ 30, the feeding speed is increased to 40ml/h·L -1 ;

(2)当发酵液OD600≥60时加入诱导剂IPTG,加量为0.5mmol/L,将发酵控制温度降低到30℃,诱导表达5小时后发酵结束,得发酵液;离心发酵液收集菌体沉淀,菌体经破菌缓冲液重悬(1kg菌体加入10L破菌缓冲液)得重悬液,重悬液经高压均质机破碎后再次离心,收集离心沉淀即为包涵体。(2) When the OD 600 of the fermentation broth is ≥60, add the inducer IPTG at an amount of 0.5 mmol/L. Reduce the fermentation control temperature to 30°C. After inducing expression for 5 hours, the fermentation is completed to obtain the fermentation broth; centrifuge the fermentation broth to collect the bacteria. The cells are precipitated, and the cells are resuspended in sterilization buffer (1kg of cells is added to 10L of sterilization buffer) to obtain a resuspension. The resuspension is broken by a high-pressure homogenizer and centrifuged again. The centrifugal precipitate is collected as inclusion bodies.

步骤(1)中所述的补料包括如下组分:酵母蛋白胨180g/L,酵母浸粉80g/L,甘油350g/L,消泡剂1g/L,溶剂为纯水。The feed material described in step (1) includes the following components: yeast peptone 180g/L, yeast extract powder 80g/L, glycerol 350g/L, defoaming agent 1g/L, and the solvent is pure water.

步骤(2)中所述的破菌缓冲液包括如下组分:三羟甲基氨基甲烷8g/L,二水合乙二胺四乙酸二钠0.5g/L,溶剂为纯水。The bacteriolysis buffer described in step (2) includes the following components: trishydroxymethylaminomethane 8g/L, disodium ethylenediaminetetraacetate dihydrate 0.5g/L, and the solvent is pure water.

称重计算得包涵体产量为0.251g/g菌体,41.6g/L发酵液The inclusion body yield calculated by weighing was 0.251g/g of bacterial cells and 41.6g/L of fermentation broth .

实施例7一种发酵培养基及其在特立帕肽制备中的应用Embodiment 7 A fermentation medium and its application in the preparation of teriparatide

所述的发酵培养基包括如下组分:酵母蛋白胨16g/L,酵母浸粉7g/L,三水磷酸氢二钾4g/L,磷酸二氢钾1.5g/L,硫酸铵2g/L,七水硫酸镁1.5g/L,甘油7g/L,微量元素溶液2ml/L,消泡剂0.3g/L,溶剂为纯水,用2mol/L氢氧化钠溶液调节pH7.2;The fermentation medium includes the following components: yeast peptone 16g/L, yeast extract powder 7g/L, dipotassium hydrogen phosphate trihydrate 4g/L, potassium dihydrogen phosphate 1.5g/L, ammonium sulfate 2g/L, seven Aqueous magnesium sulfate 1.5g/L, glycerol 7g/L, trace element solution 2ml/L, defoaming agent 0.3g/L, solvent is pure water, adjust pH to 7.2 with 2mol/L sodium hydroxide solution;

所述的微量元素溶液包括如下组分:二水合乙二胺四乙酸二钠25g/L,硫酸锰9g/L,亚铬酸亚铁15g/L,硫酸镍2g/L,氯化钴18g/L,四氯化钛1g/L,硫酸锌8g/L,硫酸铜5g/L,二水钼酸钠1g/L,硼酸3g/L,溶剂为纯水。The trace element solution includes the following components: disodium ethylenediaminetetraacetate dihydrate 25g/L, manganese sulfate 9g/L, ferrous chromite 15g/L, nickel sulfate 2g/L, cobalt chloride 18g/L. L, titanium tetrachloride 1g/L, zinc sulfate 8g/L, copper sulfate 5g/L, sodium molybdate dihydrate 1g/L, boric acid 3g/L, the solvent is pure water.

制备特立帕肽包涵体的方法,包括以下步骤:The method for preparing teriparatide inclusion bodies includes the following steps:

(1)先将除微量元素溶液以外的其他组分配置成培养基A,将微量元素溶液经0.22微米滤膜过滤后加入培养基A中,得发酵培养基,然后将种子液(OD6004.5)接入培养基中进行发酵,接种量5v/v%,初始培养条件37℃,pH7.0,通过搅拌转速和通气量及氧气控制溶解氧≥30%,其中空气和氧气的总通气量1vvm;(1) First configure other components except the trace element solution into culture medium A. Filter the trace element solution through a 0.22 micron filter membrane and add it to culture medium A to obtain the fermentation culture medium. Then add the seed liquid (OD 600 4.5 ) is inserted into the culture medium for fermentation, the inoculum volume is 5v/v%, the initial culture conditions are 37°C, pH 7.0, and the dissolved oxygen is controlled to ≥ 30% through stirring speed, ventilation and oxygen, and the total ventilation of air and oxygen is 1vvm ;

所述的发酵过程中需要变速补料,具体为:培养1小时后开始补料2.5ml/h·L-1,1.5小时后提高为5ml/h·L-1,之后每隔30分钟提高补料速度5ml/h·L-1,最高到35ml/h·L-1,当OD600≥30时补料速度提高为40ml/h·L-1The fermentation process requires variable speed feeding, specifically: starting to feed 2.5ml/h·L -1 after 1 hour of cultivation, increasing to 5ml/h·L -1 after 1.5 hours, and then increasing the feed every 30 minutes. The feeding speed is 5ml/h·L -1 , up to 35ml/h·L -1 . When OD 600 ≥ 30, the feeding speed is increased to 40ml/h·L -1 ;

(2)当发酵液OD600≥60时加入诱导剂IPTG,加量为0.5mmol/L,将发酵控制温度降低到30℃,诱导表达5小时后发酵结束,得发酵液;离心发酵液收集菌体沉淀,菌体经破菌缓冲液重悬(1kg菌体加入10L破菌缓冲液)得重悬液,重悬液经高压均质机破碎后再次离心,收集离心沉淀即为包涵体。(2) When the OD 600 of the fermentation broth is ≥60, add the inducer IPTG at an amount of 0.5 mmol/L. Reduce the fermentation control temperature to 30°C. After inducing expression for 5 hours, the fermentation is completed to obtain the fermentation broth; centrifuge the fermentation broth to collect the bacteria. The cells are precipitated, and the cells are resuspended in sterilization buffer (1kg of cells is added to 10L of sterilization buffer) to obtain a resuspension. The resuspension is broken by a high-pressure homogenizer and centrifuged again. The centrifugal precipitate is collected as inclusion bodies.

步骤(1)中所述的补料包括如下组分:酵母蛋白胨200g/L,酵母浸粉100g/L,甘油375g/L,消泡剂1.5g/L,溶剂为纯水。The feed material described in step (1) includes the following components: yeast peptone 200g/L, yeast extract powder 100g/L, glycerin 375g/L, defoaming agent 1.5g/L, and the solvent is pure water.

步骤(2)中所述的破菌缓冲液包括如下组分:三羟甲基氨基甲烷6g/L,二水合乙二胺四乙酸二钠0.4g/L,溶剂为纯水。The bacteriolysis buffer described in step (2) includes the following components: trishydroxymethylaminomethane 6g/L, disodium ethylenediaminetetraacetate dihydrate 0.4g/L, and the solvent is pure water.

称重计算得包涵体产量为0.268g/g菌体,42.8g/L发酵液The inclusion body yield calculated by weighing was 0.268g/g of bacteria and 42.8g/L of fermentation broth .

对比例1Comparative example 1

与实施例4的区别在于:不添加微量元素溶液,其他各组分含量与制备方法与实施例4相同。The difference from Example 4 is that no trace element solution is added, and the contents and preparation methods of other components are the same as those in Example 4.

称重计算得包涵体产量为0.152g/g菌体,21.1g/L发酵液The inclusion body yield calculated by weighing was 0.152g/g of bacterial cells and 21.1g/L of fermentation broth .

对比例2一种发酵培养基及其在特立帕肽制备中的应用Comparative Example 2 A fermentation medium and its application in the preparation of teriparatide

与实施例4的区别在于:诱导温度为37℃,其他各组分含量与制备方法与实施例4相同。具体为:The difference from Example 4 is that the induction temperature is 37°C, and the contents and preparation methods of other components are the same as those in Example 4. Specifically:

当发酵液OD600≥60时加入诱导剂IPTG,加量为0.3mmol/L,保持发酵温度为37℃,诱导表达5小时后发酵结束,得发酵液;离心发酵液收集菌体沉淀,菌体经破菌缓冲液重悬(1kg菌体加入10L破菌缓冲液)得重悬液,重悬液经高压均质机破碎后再次离心,收集离心沉淀即为包涵体。When the OD600 of the fermentation broth is ≥ 60, add the inducer IPTG at a dosage of 0.3mmol/L, keep the fermentation temperature at 37°C, and induce expression for 5 hours. After 5 hours of fermentation, the fermentation is completed and the fermentation broth is obtained. The fermentation broth is centrifuged to collect the bacterial precipitate. Resuspend in sterilization buffer (add 10L of sterilization buffer to 1kg of bacteria) to obtain a resuspension. The resuspension is crushed by a high-pressure homogenizer and centrifuged again. The centrifugal precipitate is collected as inclusion bodies.

称重计算得包涵体产量为0.174g/g菌体,26.8g/L发酵液The inclusion body yield calculated by weighing was 0.174g/g of bacterial cells and 26.8g/L of fermentation broth .

对比例3一种发酵培养基及其在特立帕肽制备中的应用Comparative Example 3 A fermentation medium and its application in the preparation of teriparatide

与实施例4的区别在于:不添加微量元素溶液,发酵过程中恒速补料,且诱导温度为37℃,其他各组分含量与制备方法与实施例4相同。具体为:The difference from Example 4 is that no trace element solution is added, materials are fed at a constant rate during the fermentation process, and the induction temperature is 37°C. The contents and preparation methods of other components are the same as in Example 4. Specifically:

制备特立帕肽包涵体的方法,包括以下步骤:The method for preparing teriparatide inclusion bodies comprises the following steps:

(1)将种子液(OD6004.5)接入培养基中进行发酵,接种量5v/v%,初始培养条件37℃,pH7.0,通过搅拌转速和通气量及氧气控制溶解氧≥30%,其中空气和氧气的总通气量1vvm;(1) Add the seed liquid (OD6004.5) to the culture medium for fermentation. The inoculum volume is 5v/v%. The initial culture conditions are 37°C and pH 7.0. The dissolved oxygen is controlled to ≥ 30% through stirring speed, ventilation volume and oxygen. , where the total ventilation volume of air and oxygen is 1vvm;

所述的发酵过程中需要变速补料,具体为:培养1小时后开始补料20ml/h·L-1,直到发酵结束都以此流速进行补料;The fermentation process requires variable speed feeding, specifically: starting to feed 20ml/h·L-1 after 1 hour of cultivation, and feeding at this flow rate until the end of fermentation;

(2)当发酵液OD600≥60时加入诱导剂IPTG,加量为0.1mmol/L,保持发酵温度为37℃,诱导表达5小时后发酵结束,得发酵液;离心发酵液收集菌体沉淀,菌体经破菌缓冲液重悬(1kg菌体加入5L破菌缓冲液)得重悬液,重悬液经高压均质机破碎后再次离心,收集离心沉淀即为包涵体。(2) When the OD600 of the fermentation broth is ≥ 60, add the inducer IPTG at a dosage of 0.1 mmol/L, keep the fermentation temperature at 37°C, and induce expression for 5 hours after the fermentation is completed to obtain the fermentation broth; centrifuge the fermentation broth to collect the bacterial sediment. Resuspend the bacteria in sterilization buffer (add 5L of sterilization buffer to 1kg of bacteria) to obtain a resuspension. The resuspension is crushed by a high-pressure homogenizer and centrifuged again. The centrifugal precipitate is collected as inclusion bodies.

称重计算得包涵体产量为0.166g/g菌体,23.7g/L发酵液The inclusion body yield calculated by weighing was 0.166g/g of bacterial cells and 23.7g/L of fermentation broth .

对比例4一种发酵培养基及其在特立帕肽制备中的应用Comparative Example 4 A fermentation medium and its application in the preparation of teriparatide

与实施例4的区别在于:不添加微量元素溶液,发酵过程中恒速补料,其他各组分含量与制备方法与实施例4相同。具体为:The difference from Example 4 is that no trace element solution is added, materials are fed at a constant rate during the fermentation process, and the contents and preparation methods of other components are the same as in Example 4. Specifically:

(1)将种子液(OD6004.5)接入培养基中进行发酵,接种量10v/v%,初始培养条件37℃,pH7.0,通过搅拌转速和通气量及氧气控制溶解氧≥30%,其中空气和氧气的总通气量1.5vvm;(1) Add the seed liquid (OD6004.5) to the culture medium for fermentation. The inoculum volume is 10v/v%. The initial culture conditions are 37°C and pH 7.0. The dissolved oxygen is controlled to ≥30% through stirring speed, ventilation volume and oxygen. , where the total ventilation volume of air and oxygen is 1.5vvm;

所述的发酵过程中需要变速补料,具体为:培养1小时后开始补料20ml/h·L-1,直到发酵结束都以此流速进行补料。The fermentation process requires variable speed feeding, specifically: starting feeding at 20 ml/h·L-1 after 1 hour of cultivation, and feeding at this flow rate until the end of fermentation.

称重计算得包涵体产量为0.168g/g菌体,25.9g/L发酵液The inclusion body yield calculated by weighing was 0.168g/g of bacterial cells and 25.9g/L of fermentation broth .

对比例5Comparative example 5

与实施例4的区别在于:不含有亚铬酸亚铁,增加七水硫酸亚铁32g/L,其他各组分含量与制备方法与实施例4相同。即:The difference from Example 4 is that it does not contain ferrous chromite, 32 g/L of ferrous sulfate heptahydrate is added, and the contents and preparation methods of other components are the same as those in Example 4. Right now:

所述的微量元素溶液包括如下组分:二水合乙二胺四乙酸二钠30g/L,硫酸锰10g/L,七水硫酸亚铁32g/L,硫酸镍3g/L,氯化钴20g/L,四氯化钛2g/L,硫酸锌10g/L,硫酸铜6g/L,二水钼酸钠1.5g/L,硼酸4g/L,溶剂为纯水。The trace element solution includes the following components: disodium ethylenediaminetetraacetate dihydrate 30g/L, manganese sulfate 10g/L, ferrous sulfate heptahydrate 32g/L, nickel sulfate 3g/L, cobalt chloride 20g/L. L, titanium tetrachloride 2g/L, zinc sulfate 10g/L, copper sulfate 6g/L, sodium molybdate dihydrate 1.5g/L, boric acid 4g/L, the solvent is pure water.

称重计算得包涵体产量为0.231g/g菌体,36.2g/L发酵液The inclusion body yield calculated by weighing was 0.231g/g of bacterial cells and 36.2g/L of fermentation broth .

对比例6Comparative example 6

与实施例4的区别在于:不含有四氯化钛,其他各组分含量与制备方法与实施例4相同。即:The difference from Example 4 is that it does not contain titanium tetrachloride, and the contents and preparation methods of other components are the same as those in Example 4. Right now:

所述的微量元素溶液包括如下组分:二水合乙二胺四乙酸二钠30g/L,硫酸锰10g/L,亚铬酸亚铁20g/L,硫酸镍3g/L,氯化钴20g/L,硫酸锌10g/L,硫酸铜6g/L,二水钼酸钠1.5g/L,硼酸4g/L,溶剂为纯水。The trace element solution includes the following components: disodium ethylenediaminetetraacetate dihydrate 30g/L, manganese sulfate 10g/L, ferrous chromite 20g/L, nickel sulfate 3g/L, cobalt chloride 20g/L. L, zinc sulfate 10g/L, copper sulfate 6g/L, sodium molybdate dihydrate 1.5g/L, boric acid 4g/L, the solvent is pure water.

称重计算得包涵体产量为0.232g/g菌体,36.9g/L发酵液The inclusion body yield calculated by weighing was 0.232g/g of bacterial cells and 36.9g/L of fermentation broth .

对比例7Comparative example 7

与实施例4的区别在于:不含有硫酸镍,其他各组分含量与制备方法与实施例4相同。即:The difference from Example 4 is that it does not contain nickel sulfate, and the contents and preparation methods of other components are the same as those in Example 4. Right now:

所述的微量元素溶液包括如下组分:所述的微量元素溶液包括如下组分:二水合乙二胺四乙酸二钠30g/L,硫酸锰10g/L,亚铬酸亚铁20g/L,氯化钴20g/L,四氯化钛2g/L,硫酸锌10g/L,硫酸铜6g/L,二水钼酸钠1.5g/L,硼酸4g/L,溶剂为纯水。The trace element solution includes the following components: the trace element solution includes the following components: disodium ethylenediaminetetraacetate dihydrate 30g/L, manganese sulfate 10g/L, ferrous chromite 20g/L, Cobalt chloride 20g/L, titanium tetrachloride 2g/L, zinc sulfate 10g/L, copper sulfate 6g/L, sodium molybdate dihydrate 1.5g/L, boric acid 4g/L, the solvent is pure water.

称重计算得包涵体产量为0.241g/g菌体,37.6g/L发酵液The inclusion body yield calculated by weighing was 0.241g/g of bacterial cells and 37.6g/L of fermentation broth .

对比例8Comparative example 8

与实施例4的区别在于:不含有硫酸镍和四氯化钛,其他各组分含量与制备方法与实施例4相同。即:The difference from Example 4 is that it does not contain nickel sulfate and titanium tetrachloride, and the contents and preparation methods of other components are the same as those in Example 4. Right now:

所述的微量元素溶液包括如下组分:二水合乙二胺四乙酸二钠30g/L,硫酸锰10g/L,亚铬酸亚铁20g/L,氯化钴20g/L,硫酸锌10g/L,硫酸铜6g/L,二水钼酸钠1.5g/L,硼酸4g/L,溶剂为纯水。The trace element solution includes the following components: disodium ethylenediaminetetraacetate dihydrate 30g/L, manganese sulfate 10g/L, ferrous chromite 20g/L, cobalt chloride 20g/L, zinc sulfate 10g/L. L, copper sulfate 6g/L, sodium molybdate dihydrate 1.5g/L, boric acid 4g/L, and the solvent is pure water.

称重计算得包涵体产量为0.226g/g菌体,34.8g/L发酵液The inclusion body yield calculated by weighing was 0.226g/g of bacterial cells and 34.8g/L of fermentation broth .

对比例9Comparative example 9

与实施例4的区别在于:加入硫酸镍4.8g/L和四氯化钛0.2g/L,其他各组分含量与制备方法与实施例4相同。即:The difference from Example 4 is that 4.8 g/L of nickel sulfate and 0.2 g/L of titanium tetrachloride are added, and the contents and preparation methods of other components are the same as those in Example 4. Right now:

所述的微量元素溶液包括如下组分:二水合乙二胺四乙酸二钠30g/L,硫酸锰10g/L,亚铬酸亚铁20g/L,硫酸镍4.8g/L,氯化钴20g/L,四氯化钛0.2g/L,硫酸锌10g/L,硫酸铜6g/L,二水钼酸钠1.5g/L,硼酸4g/L,溶剂为纯水。The trace element solution includes the following components: disodium ethylenediaminetetraacetate dihydrate 30g/L, manganese sulfate 10g/L, ferrous chromite 20g/L, nickel sulfate 4.8g/L, cobalt chloride 20g /L, titanium tetrachloride 0.2g/L, zinc sulfate 10g/L, copper sulfate 6g/L, sodium molybdate dihydrate 1.5g/L, boric acid 4g/L, the solvent is pure water.

称重计算得包涵体产量为0.233g/g菌体,36.4g/L发酵液The inclusion body yield calculated by weighing was 0.233g/g of bacterial cells and 36.4g/L of fermentation broth .

对比例10Comparative example 10

与实施例4的区别在于:加入亚铬酸亚铁2g/L和四氯化钛3.3g/L,七水硫酸亚铁30g/L,其他各组分含量与制备方法与实施例4相同。即:The difference from Example 4 is that 2 g/L of ferrous chromite, 3.3 g/L of titanium tetrachloride, and 30 g/L of ferrous sulfate heptahydrate are added. The contents and preparation methods of other components are the same as those of Example 4. Right now:

所述的微量元素溶液包括如下组分:二水合乙二胺四乙酸二钠30g/L,硫酸锰10g/L,亚铬酸亚铁2g/L,硫酸镍3g/L,氯化钴20g/L,四氯化钛3.3g/L,硫酸锌10g/L,硫酸铜6g/L,二水钼酸钠1.5g/L,硼酸4g/L,七水硫酸亚铁30g/L,溶剂为纯水。The trace element solution includes the following components: disodium ethylenediaminetetraacetate dihydrate 30g/L, manganese sulfate 10g/L, ferrous chromite 2g/L, nickel sulfate 3g/L, cobalt chloride 20g/L. L, titanium tetrachloride 3.3g/L, zinc sulfate 10g/L, copper sulfate 6g/L, sodium molybdate dihydrate 1.5g/L, boric acid 4g/L, ferrous sulfate heptahydrate 30g/L, the solvent is pure water.

称重计算得包涵体产量为0.227g/g菌体,34.5g/L发酵液The inclusion body yield calculated by weighing was 0.227g/g of bacterial cells and 34.5g/L of fermentation broth .

对比例11Comparative example 11

与实施例4的区别在于:所述的微量元素溶液包括如下组分:硫酸亚铁3.2g/L、氯化亚锰1g/L、硝酸钴1.5g/L、氯化钙1g/L、氯化铜0.25g/L、硫酸锌0.4g/L、硼酸0.3g/L和钼酸钠3g/L,溶剂为1mol/L盐酸,其他各组分含量与制备方法与实施例4相同。The difference from Example 4 is that the trace element solution includes the following components: ferrous sulfate 3.2g/L, manganous chloride 1g/L, cobalt nitrate 1.5g/L, calcium chloride 1g/L, chlorine Copper oxide 0.25g/L, zinc sulfate 0.4g/L, boric acid 0.3g/L and sodium molybdate 3g/L, the solvent is 1mol/L hydrochloric acid, and the content and preparation method of other components are the same as in Example 4.

称重计算得包涵体产量为0.199g/g菌体,28.9g/L发酵液The inclusion body yield calculated by weighing was 0.199g/g of bacterial cells and 28.9g/L of fermentation broth .

效果数据:Performance data:

比较各实施例和对比例的包涵体产量,结果见表1。Compare the inclusion body yields of each embodiment and the comparative example, and the results are shown in Table 1.

表1Table 1

根据上表1的检测结果可以看出,本发明实施例1-5提供的发酵培养基用于制备特立帕肽包涵体,得到的包涵体产量≥0.241g/g菌体,≥40.1g/L发酵液;而对比例中改变微量元素溶液中元素的种类,含量或省略微量元素溶液,或者改变发酵过程中的补料方式均会导致包涵体产量的降低。According to the test results in Table 1 above, it can be seen that the fermentation medium provided in Examples 1-5 of the present invention is used to prepare teriparatide inclusion bodies, and the yield of the inclusion bodies obtained is ≥0.241g/g bacterial cells , ≥40.1g/ L fermentation broth ; in the comparative example, changing the type and content of elements in the trace element solution or omitting the trace element solution, or changing the feeding method during the fermentation process will lead to a reduction in the production of inclusion bodies.

以上实施例仅用于说明本发明的技术方案而非对其限制,尽管参照上述实施例对本发明进行了详细说明,所属领域的普通技术人员依然可以对本发明的具体实施方案进行修改或者等同替换,而这些并未脱离本发明精神和范围的任何修改或者等同替换,其均在本发明的权利要求保护范围之内。The above embodiments are only used to illustrate the technical solutions of the present invention but not to limit them. Although the present invention has been described in detail with reference to the above embodiments, those of ordinary skill in the art can still make modifications or equivalent substitutions to the specific implementations of the present invention. Any modifications or equivalent substitutions that do not depart from the spirit and scope of the present invention are within the scope of the claims of the present invention.

Claims (15)

1.一种发酵培养基,其特征在于:包括如下组分:酵母蛋白胨12-20g/L,酵母浸粉4-10g/L,三水磷酸氢二钾3-5g/L,磷酸二氢钾0.5-2g/L,硫酸铵0.5-3g/L,七水硫酸镁0.5-2g/L,甘油3-10g/L,微量元素溶液1-3ml/L,消泡剂0.1-0.5g/L,溶剂为纯水,用2mol/L氢氧化钠溶液调节pH6.8-7.2;1. A fermentation medium, characterized in that: it includes the following components: yeast peptone 12-20g/L, yeast extract powder 4-10g/L, dipotassium hydrogen phosphate trihydrate 3-5g/L, potassium dihydrogen phosphate 0.5-2g/L, ammonium sulfate 0.5-3g/L, magnesium sulfate heptahydrate 0.5-2g/L, glycerin 3-10g/L, trace element solution 1-3ml/L, defoaming agent 0.1-0.5g/L, The solvent is pure water, and the pH is adjusted to 6.8-7.2 with 2mol/L sodium hydroxide solution; 所述的微量元素溶液中含有硫酸镍、四氯化钛和亚铬酸亚铁。The trace element solution contains nickel sulfate, titanium tetrachloride and ferrous chromite. 2.根据权利要求1所述的发酵培养基,其特征在于:所述的硫酸镍、四氯化钛和亚铬酸亚铁的浓度分别为1-3g/L、0.5-2g/L和10-20g/L。2. The fermentation medium according to claim 1, characterized in that: the concentrations of described nickel sulfate, titanium tetrachloride and ferrous chromite are 1-3g/L, 0.5-2g/L and 10 respectively. -20g/L. 3.根据权利要求2所述的发酵培养基,其特征在于:所述的微量元素溶液还包括如下组分:二水合乙二胺四乙酸二钠、硫酸锰、二水钼酸钠、氯化钴、硫酸锌、硫酸铜和硼酸,溶剂为纯水。3. The fermentation culture medium according to claim 2, characterized in that: the trace element solution further includes the following components: disodium ethylenediaminetetraacetate dihydrate, manganese sulfate, sodium molybdate dihydrate, chloride Cobalt, zinc sulfate, copper sulfate and boric acid, the solvent is pure water. 4.根据权利要求3所述的发酵培养基,其特征在于:所述的微量元素溶液还包括如下浓度的组分:二水合乙二胺四乙酸二钠20-30g/L,硫酸锰8-10g/L,二水钼酸钠0.5-1.5g/L,氯化钴16-20g/L,硫酸锌6-10g/L,硫酸铜4-6g/L和硼酸2-4g/L,溶剂为纯水。4. The fermentation culture medium according to claim 3, characterized in that: the trace element solution also includes components of the following concentration: disodium ethylenediaminetetraacetate dihydrate 20-30g/L, manganese sulfate 8- 10g/L, sodium molybdate dihydrate 0.5-1.5g/L, cobalt chloride 16-20g/L, zinc sulfate 6-10g/L, copper sulfate 4-6g/L and boric acid 2-4g/L, the solvent is Pure water. 5.权利要求1所述的发酵培养基在特立帕肽制备中的应用。5. Application of the fermentation medium according to claim 1 in the preparation of teriparatide. 6.权利要求1所述的发酵培养基制备特立帕肽包涵体的方法,其特征在于:包括以下步骤:6. The method for preparing teriparatide inclusion bodies from a fermentation medium according to claim 1, characterized in that it includes the following steps: (1)先将除微量元素溶液以外的其他组分配置成培养基A,然后将微量元素溶液经过滤后加入培养基A中,得到发酵培养基;再将种子液接入培养基,进行发酵;(1) First configure other components except the trace element solution into culture medium A, then filter the trace element solution and add it to culture medium A to obtain a fermentation medium; then add the seed liquid to the culture medium for fermentation ; (2)当发酵液OD600≥60时加入诱导剂并降温,诱导表达5-7小时后发酵结束,得发酵液;首先离心发酵液收集菌体沉淀,菌体沉淀经重悬、破碎、离心后得到粗包涵体。(2) When the OD600 of the fermentation broth is ≥ 60, add the inducer and cool down. After 5-7 hours of induced expression, the fermentation is completed and the fermentation broth is obtained. First, centrifuge the fermentation broth to collect the bacterial precipitate. The bacterial precipitate is resuspended, broken, and centrifuged. Crude inclusion bodies were obtained. 7.根据权利要求6所述的方法,其特征在于:步骤(1)中所述的种子液的接种量为5-10v/v%,初始培养条件37℃,pH6.7-7.3,溶解氧≥30%。7. The method according to claim 6, characterized in that: the inoculum amount of the seed liquid described in step (1) is 5-10v/v%, the initial culture conditions are 37°C, pH 6.7-7.3, and dissolved oxygen ≥30%. 8.根据权利要求6所述的方法,其特征在于:所述的溶氧量通过搅拌转速和通气量及氧气控制,其中空气和氧气的总通气量为1-1.5vvm。8. The method according to claim 6, characterized in that: the amount of dissolved oxygen is controlled by stirring speed, ventilation volume and oxygen, wherein the total ventilation volume of air and oxygen is 1-1.5 vvm. 9.根据权利要求6所述的方法,其特征在于:步骤(1)中所述的发酵过程中需流加补料,并随着微生物菌体的密度提高需要逐渐增加补料的流速。9. The method according to claim 6, characterized in that: during the fermentation process in step (1), feeding material needs to be fed, and as the density of the microbial cells increases, the flow rate of the feeding material needs to be gradually increased. 10.根据权利要求9所述的方法,其特征在于:所述的添加补料的方式为变速补料,所述的变速补料方案如下:培养1小时后开始补料2.5ml/h·L-1,1.5小时后提高为5ml/h·L-1,之后每隔30分钟提高补料速度5ml/h·L-1,最高到35ml/h·L-1,当OD600≥30时补料速度提高为40ml/h·L-110. The method according to claim 9, characterized in that: the method of adding feed is variable speed feeding, and the variable speed feeding scheme is as follows: start feeding 2.5ml/h·L after 1 hour of cultivation. -1 , increase to 5ml/h·L -1 after 1.5 hours, then increase the feeding rate by 5ml/h·L -1 every 30 minutes, up to 35ml/h·L -1 , feed when OD600≥30 The speed is increased to 40ml/h·L -1 . 11.根据权利要求9所述的方法,其特征在于:所述的补料包括如下组分:酵母蛋白胨180-220g/L,酵母浸粉80-120g/L,甘油350-400g/L,消泡剂1-2g/L,溶剂为纯水。11. The method according to claim 9, characterized in that: the supplement includes the following components: yeast peptone 180-220g/L, yeast extract powder 80-120g/L, glycerin 350-400g/L, digestion The foaming agent is 1-2g/L, and the solvent is pure water. 12.根据权利要求6所述的方法,其特征在于:步骤(2)中所述的诱导剂为IPTG,所述的诱导剂的加入量为0.1-0.5mmol/L。12. The method according to claim 6, characterized in that: the inducer described in step (2) is IPTG, and the addition amount of the inducer is 0.1-0.5 mmol/L. 13.根据权利要求6所述的方法,其特征在于:步骤(2)中所述的降温温度为30℃。13. The method according to claim 6, characterized in that: the cooling temperature in step (2) is 30°C. 14.根据权利要求6所述的方法,其特征在于:步骤(3)中所述的重悬操作为:向菌体沉淀中加入破菌缓冲液后重悬,得重悬液;所述的菌体沉淀与破菌缓冲液的质量体积比为1kg:5-20L。14. The method according to claim 6, characterized in that: the resuspension operation described in step (3) is: adding bacteriostasis buffer to the bacterial sediment and resuspension to obtain a resuspension; The mass-volume ratio of bacterial sediment and bacteriolysis buffer is 1kg:5-20L. 15.根据权利要求14所述的方法,其特征在于:所述的破菌缓冲液包括如下组分:三羟甲基氨基甲烷4-8g/L,二水合乙二胺四乙酸二钠0.2-0.5g/L,溶剂为纯水。15. The method according to claim 14, characterized in that: the bacteriolysis buffer includes the following components: trishydroxymethylaminomethane 4-8g/L, disodium ethylenediaminetetraacetate dihydrate 0.2- 0.5g/L, the solvent is pure water.
CN202311681973.1A 2023-12-08 2023-12-08 Fermentation medium and application thereof in preparation of teriparatide Withdrawn CN117736962A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN202311681973.1A CN117736962A (en) 2023-12-08 2023-12-08 Fermentation medium and application thereof in preparation of teriparatide
CN202410859533.9A CN118703415B (en) 2023-12-08 2024-06-28 Fermentation medium and its application in the preparation of teriparatide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202311681973.1A CN117736962A (en) 2023-12-08 2023-12-08 Fermentation medium and application thereof in preparation of teriparatide

Publications (1)

Publication Number Publication Date
CN117736962A true CN117736962A (en) 2024-03-22

Family

ID=90253659

Family Applications (2)

Application Number Title Priority Date Filing Date
CN202311681973.1A Withdrawn CN117736962A (en) 2023-12-08 2023-12-08 Fermentation medium and application thereof in preparation of teriparatide
CN202410859533.9A Active CN118703415B (en) 2023-12-08 2024-06-28 Fermentation medium and its application in the preparation of teriparatide

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN202410859533.9A Active CN118703415B (en) 2023-12-08 2024-06-28 Fermentation medium and its application in the preparation of teriparatide

Country Status (1)

Country Link
CN (2) CN117736962A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118703415A (en) * 2023-12-08 2024-09-27 亿帆医药(上海)有限公司 Fermentation medium and its application in the preparation of teriparatide

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100145033A1 (en) * 2007-08-09 2010-06-10 Usv Limited Novel orthogonal process for purification of recombinant human parathyroid hormone (rhpth) (1-34)
US20190169675A1 (en) * 2016-08-12 2019-06-06 Lonza Ltd Proteomic analysis of host cell proteins
CN111378027A (en) * 2018-12-29 2020-07-07 万新医药科技(苏州)有限公司 Preparation method of somaglutide precursor
KR20200119743A (en) * 2019-04-10 2020-10-20 순천대학교 산학협력단 The mass production process of teriparatide using E.coli
CN112625117A (en) * 2020-12-23 2021-04-09 无锡和邦生物科技有限公司 Non-denaturing purification method and application of soluble recombinant teriparatide
CN114672531A (en) * 2020-12-24 2022-06-28 江苏万邦医药科技有限公司 A method for increasing the expression of Escherichia coli protein through phase dissolved oxygen control

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1810978A (en) * 2005-01-27 2006-08-02 深圳市东西方生物技术有限公司 Process of culturing micro algae to produce isotope glucose
CN107801733A (en) * 2017-10-25 2018-03-16 安徽古尔特科技有限公司 Titania nanoparticles suppress the New function of Escherichia coli Growth
CN109234223B (en) * 2018-11-21 2021-01-19 南京基蛋生物医药有限公司 Low-protein serum-free cell culture medium
EP4069190A1 (en) * 2019-12-06 2022-10-12 Nanexa AB New composition
CN113969257B (en) * 2020-07-25 2024-09-27 鲁南制药集团股份有限公司 Culture medium for producing insulin glargine
CN117736962A (en) * 2023-12-08 2024-03-22 亿帆医药(上海)有限公司 Fermentation medium and application thereof in preparation of teriparatide

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100145033A1 (en) * 2007-08-09 2010-06-10 Usv Limited Novel orthogonal process for purification of recombinant human parathyroid hormone (rhpth) (1-34)
US20190169675A1 (en) * 2016-08-12 2019-06-06 Lonza Ltd Proteomic analysis of host cell proteins
CN111378027A (en) * 2018-12-29 2020-07-07 万新医药科技(苏州)有限公司 Preparation method of somaglutide precursor
KR20200119743A (en) * 2019-04-10 2020-10-20 순천대학교 산학협력단 The mass production process of teriparatide using E.coli
CN112625117A (en) * 2020-12-23 2021-04-09 无锡和邦生物科技有限公司 Non-denaturing purification method and application of soluble recombinant teriparatide
CN114672531A (en) * 2020-12-24 2022-06-28 江苏万邦医药科技有限公司 A method for increasing the expression of Escherichia coli protein through phase dissolved oxygen control

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
刘丰亮;常宏;刘洁;杨克;张杰;: "重组人甲状旁腺素(rhPTH(1-84))的原核表达及发酵条件初步优化", 云南大学学报(自然科学版), no. 02, 15 March 2008 (2008-03-15) *
刘颗星;邓颂波;曾日祥;黄文显;石林毅;: "特立帕肽在老年性股骨粗隆间骨折保守治疗中对骨密度的影响及其临床疗效", 临床与病理杂志, no. 12, 28 December 2019 (2019-12-28) *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118703415A (en) * 2023-12-08 2024-09-27 亿帆医药(上海)有限公司 Fermentation medium and its application in the preparation of teriparatide
CN118703415B (en) * 2023-12-08 2025-02-14 亿帆医药(上海)有限公司 Fermentation medium and its application in the preparation of teriparatide

Also Published As

Publication number Publication date
CN118703415B (en) 2025-02-14
CN118703415A (en) 2024-09-27

Similar Documents

Publication Publication Date Title
CN101914603B (en) Fermentation method for production of recombination protein by lactose-induced pMFH carrier
CN117736962A (en) Fermentation medium and application thereof in preparation of teriparatide
CN102154189A (en) Fermentation culture method of rhG-CSF (recombinant human granulocyte colony-stimulating factor) recombination engineering bacteria
CN113502310B (en) Method for preparing semaglutide precursor through high-density fermentation
CN107937459A (en) It is a kind of can scale production TRIM72 albumen fermentation process in high density
CN104592381A (en) Preparation method of liraglutide intermediate polypeptide
PT956042E (en) Mycosis vaccines
CN1308033C (en) Medicine for decreasing vagina acidity and treating vaginitis, use thereof
CN116425839A (en) Human papillomavirus polypeptide and application thereof
WO2025190352A1 (en) Method for preparing recombinant human albumin with high expression and low o-glycosylation level
CN104152515A (en) Medium used for preparation of recombinant human granulocyte colony stimulating factor and fermentation method
JP3319597B2 (en) Β-aretin useful for cell culture and therapy
CN112725231A (en) Fermentation method for large-scale efficient expression of supercoiled plasmid DNA by escherichia coli
CN110241034B (en) A strain of grape Hansenula and its application
CN111909859A (en) Pichia pastoris low-temperature culture medium
CN112391431B (en) Fermentation medium and fermentation method for recombinant leukocyte inhibitory factor and hirudin chimeric protein
CN102660613B (en) For the high density fermentation culture medium and preparation method thereof of recombination chicken interferon alpha
RU2807548C1 (en) Strain of escherichia coli bacteria with reduced ability to accumulate acetate - producer of hybrid polypeptide containing proinsulin glargine
CN114478795B (en) Fusion protein for improving stability of oral administration of polypeptide drugs and application thereof
CN108623655A (en) Improve the dipeptides EL and application thereof of insulin resistance
CN114958617B (en) Pleurotus ostreatus with high ergothioneine yield and application thereof
CN114317385B (en) Fermentation medium and fermentation process for promoting secretion and expression of HER2 affibody protein
CN116410908A (en) Preparation method and application of insulin aspart
CN112080533B (en) Full-nutrition fed-batch fermentation control process for improving yield of L-isoleucine
CN102533825A (en) Preparation method of recombinant carboxypeptidase B

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication

Application publication date: 20240322